MIRM (STOCKS)
Mirum Pharmaceuticals, Inc. Common Stock
$98.770000
-0.200000 (-0.20%)
Prev close: $98.970000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Christopher Peetz
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $6,406.21M
- Employees
- 355
- P/E (TTM)
- -6.80
- P/B (TTM)
- -614.91
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $618.07M |
| Benefits Costs and Expenses | $1.48B |
| Costs And Expenses | $1.48B |
| Operating Expenses | $1.45B |
| Selling, General, and Administrative Expenses | $313.84M |
| Other Operating Expenses | $1.14B |
| Operating Income/Loss | -$833.97M |
| Income/Loss From Continuing Operations After Tax | -$860.21M |
| Income/Loss From Continuing Operations Before Tax | -$857.54M |
| Income Tax Expense/Benefit | $2.67M |
| Net Income/Loss | -$860.21M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$860.21M |
| Net Income/Loss Available To Common Stockholders, Basic | -$860.21M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$14.55 |
| Diluted Earnings Per Share | -$14.56 |
| Basic Average Shares | 173,304,635 |
| Diluted Average Shares | 179,659,245 |
| Assets | $1.04B |
| Current Assets | $636.31M |
| Inventory | $25.77M |
| Other Current Assets | $610.54M |
| Noncurrent Assets | $408.67M |
| Fixed Assets | $2.25M |
| Intangible Assets | $247.39M |
| Other Non-current Assets | $159.03M |
| Liabilities | $1.06B |
| Current Liabilities | $222.79M |
| Accounts Payable | $23.43M |
| Wages | $28.39M |
| Other Current Liabilities | $170.97M |
| Noncurrent Liabilities | $832.62M |
| Equity | -$10.42M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$10.42M |
| Liabilities And Equity | $1.04B |
| Net Cash Flow From Operating Activities | -$227.27M |
| Net Cash Flow From Operating Activities, Continuing | -$227.27M |
| Net Cash Flow From Investing Activities | -$172.78M |
| Net Cash Flow From Investing Activities, Continuing | -$172.78M |
| Net Cash Flow From Financing Activities | $506.61M |
| Net Cash Flow From Financing Activities, Continuing | $506.61M |
| Net Cash Flow | $106.56M |
| Net Cash Flow, Continuing | $106.56M |
| Comprehensive Income/Loss | -$861.23M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$861.23M |
| Other Comprehensive Income/Loss | $1.88M |